Finally, eight targets were screened through conjoint analysis and experimental verification showed that six of them including FASN, AKT1, CASP3, F2, PTGS2 and PRKCA, could be modulated by CRP in NAFLD mice. The gene discussed is FASN; the disease is metabolic dysfunction-associated steatotic liver disease.